CLEC4D and neoplasm: C-type lectin receptors are emerging orchestrators of sterile inflammation and represent potential therapeutic targets in many cancers, including PCa (Chiffoleau, 2018). C-type lectins were shown to facilitate tumor metastasis (Ding et al., 2017).